Droia.PNG
Droia Oncology Ventures raises second fund of EUR 150 million
December 10, 2018 12:53 ET | Droia Oncology Ventures
Droia Oncology Ventures raises second fund of EUR 150 million December 10th 2018: Droia, a specialist investor focused on oncology therapeutics, announced the closing of Droia II, its second fund, at...
Tusk-logo.jpg
Tusk Therapeutics to be acquired by Roche
September 28, 2018 01:30 ET | Tusk Therapeutics Ltd
  Tusk Therapeutics to be acquired by Roche Stevenage, United Kingdom – September 28th 2018:  Tusk Therapeutics Ltd (“Tusk”) was today acquired by Roche. Tusk has developed an antibody with a novel...